Mirae Asset Global Investments Co., Ltd. Regenxbio Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,938 shares of RGNX stock, worth $23,914. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,938
Previous 1,631
18.82%
Holding current value
$23,914
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RGNX
# of Institutions
181Shares Held
45.2MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$106 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$58.9 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$53.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$42.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$22.8 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $533M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...